Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Administrative Officer

Chief Financial Officer

CSO & CMO

Chief Executive Officer

See Remarks

Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program to permanently turn off the ANGPTL3 gene in the liver. It has a collaboration and license agreement with Beam Therapeutics Inc.; a development and option agreement with Acuitas Therapeutics, Inc.; and a Cas9 license agreement with The Broad Institute and the President and Fellows of Harvard College. The company was formerly known as Endcadia, Inc. and changed its name to Verve Therapeutics, Inc. in January 2019. Verve Therapeutics, Inc. was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.

Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular d...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-02	Premium	sold	Premium	Premium	Premium	Chief Administrative Officer
2024-04-01	Premium	acquired	Premium	Premium	Premium	Chief Administrative Officer
2023-12-01	Premium	bought	Premium	Premium	Premium	-
2023-11-29	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2023-11-29	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2023-09-18	Premium	gifted	Premium	Premium	Premium	-
2023-09-18	Premium	gifted	Premium	Premium	Premium	-
2023-08-11	Premium	gifted	Premium	Premium	Premium	-
2023-08-11	Premium	gifted	Premium	Premium	Premium	-
2022-12-14	Premium	acquired	Premium	Premium	Premium	CSO & CMO
2022-12-01	Premium	sold	Premium	Premium	Premium	CSO & CMO
2022-11-29	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2022-11-29	Premium	sold	Premium	Premium	Premium	Chief Financial Officer
2022-11-07	Premium	gifted	Premium	Premium	Premium	-
2022-11-07	Premium	gifted	Premium	Premium	Premium	-
2022-11-04	Premium	sold	Premium	Premium	Premium	-
2022-11-04	Premium	sold	Premium	Premium	Premium	-
2022-11-04	Premium	sold	Premium	Premium	Premium	-
2022-11-04	Premium	sold	Premium	Premium	Premium	-
2022-11-04	Premium	sold	Premium	Premium	Premium	-
2022-11-03	Premium	sold	Premium	Premium	Premium	-
2022-11-03	Premium	sold	Premium	Premium	Premium	-
2022-11-03	Premium	sold	Premium	Premium	Premium	-
2022-11-03	Premium	sold	Premium	Premium	Premium	-
2022-11-03	Premium	sold	Premium	Premium	Premium	-

VERV - Verve Therapeutics, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for VERV